BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Fernandez CJ, Agarwal M, Pottakkat B, Haroon NN, George AS, Pappachan JM. Gastroenteropancreatic neuroendocrine neoplasms: A clinical snapshot. World J Gastrointest Surg 2021; 13(3): 231-255 [PMID: 33796213 DOI: 10.4240/wjgs.v13.i3.231]
URL: https://www.wjgnet.com/1007-9327/full/v13/i3/231.htm
Number Citing Articles
1
Andrew Canakis, Linda S Lee. Current updates and future directions in diagnosis and management of gastroenteropancreatic neuroendocrine neoplasmsWorld Journal of Gastrointestinal Endoscopy 2022; 14(5): 267-290 doi: 10.4253/wjge.v14.i5.267
2
D. A. Salimgereeva, I. Y. Feidorov, I. E. Khatkov. Pancreatic resections or observation in management of sporadic non-functioning stage T1 neuroendocrine tumors of the pancreas (PNET) (literature review)Endocrine Surgery 2023; 17(1): 35 doi: 10.14341/serg12775
3
Juni Banerjee, Ramya P. Ranjan, Md. Tanjim Alam, Sanika Deshmukh, Prem Prakash Tripathi, Sonu Gandhi, Shuvomoy Banerjee. Virus-associated neuroendocrine cancers: Pathogenesis and current therapeuticsPathology - Research and Practice 2023; 248: 154720 doi: 10.1016/j.prp.2023.154720
4
Kamran Shateri, Fatemeh Halimi shabestari, Mohammad Reza Pashaei. Gallstone Frequency in Adults With Celiac Disease: Results of a Population-Based Celiac Disease Registry From West Azerbaijan, IRANDisease and Diagnosis 2022; 11(1): 14 doi: 10.34172/ddj.2022.04
5
Matteo Regolo, Nicolas Cardaci, Clara Salmeri, Alfredo Laudani, Michele Colaci, Massimo Ippolito, Fabio Motta, Salvatore Magrì, Stefanie Parisi, Alfredo Gaetano Torcitto, Lorenzo Malatino. Pancreatic Neuroendocrine Tumor (Pan-NET) Presented by Abdominal Pain: A Case Report and Literature ReviewJournal of Clinical Medicine 2023; 12(20): 6617 doi: 10.3390/jcm12206617
6
Cecilie Slott, Seppo W. Langer, Stine Møller, Jesper Krogh, Marianne Klose, Carsten Palnæs Hansen, Andreas Kjaer, Pernille Holmager, Rajendra Singh Garbyal, Ulrich Knigge, Mikkel Andreassen. Outlook for 615 Small Intestinal Neuroendocrine Tumor Patients: Recurrence Risk after Surgery and Disease-Specific Survival in Advanced DiseaseCancers 2024; 16(1): 204 doi: 10.3390/cancers16010204
7
Niko Hiltunen, Niko Kemi, Juha P. Väyrynen, Jan Böhm, Joonas H. Kauppila, Heikki Huhta, Olli Helminen, Luwen Zhang. Toll-like receptors 1–9 in small bowel neuroendocrine tumors–Clinical significance and prognosisPLOS ONE 2024; 19(5): e0302813 doi: 10.1371/journal.pone.0302813
8
Sanjana Ballal, Madhav P. Yadav, Madhavi Tripathi, Ranjit Kumar Sahoo, Chandrasekhar Bal. Survival Outcomes in Metastatic Gastroenteropancreatic Neuroendocrine Tumor Patients Receiving Concomitant225Ac-DOTATATE–Targeted α-Therapy and Capecitabine: A Real-World-Scenario Management-Based Long-Term Outcome StudyJournal of Nuclear Medicine 2023; 64(2): 211 doi: 10.2967/jnumed.122.264043
9
Ludovica Magi, Matteo Marasco, Maria Rinzivillo, Antongiulio Faggiano, Francesco Panzuto. Management of Functional Pancreatic Neuroendocrine NeoplasmsCurrent Treatment Options in Oncology 2023; 24(7): 725 doi: 10.1007/s11864-023-01085-0
10
Emma N. Rizen, Alexandria T. Phan. Neuroendocrine Tumors: a Relevant Clinical UpdateCurrent Oncology Reports 2022; 24(6): 703 doi: 10.1007/s11912-022-01217-z
11
Francesca Corti, Roberta Elisa Rossi, Pietro Cafaro, Gaia Passarella, Antonella Turla, Sara Pusceddu, Jorgelina Coppa, Simone Oldani, Alessandro Guidi, Raffaella Longarini, Diego Luigi Cortinovis. Emerging Treatment Options for Neuroendocrine Neoplasms of Unknown Primary Origin: Current Evidence and Future PerspectivesCancers 2024; 16(11): 2025 doi: 10.3390/cancers16112025
12
Christopher Sakellis, Heather A. Jacene. Neuroendocrine TumorsPET Clinics 2024; 19(3): 325 doi: 10.1016/j.cpet.2024.03.008
13
Wei Wang, Bo Zhang, Yue Zhang, Pinyi Ma, Xinghua Wang, Ying Sun, Daqian Song, Qiang Fei. Colorimetry and SERS dual-mode sensing of serotonin based on functionalized gold nanoparticlesSpectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2021; 261: 120057 doi: 10.1016/j.saa.2021.120057
14
Catherine H. Davis, Amanda M. Laird, Steven K. Libutti. Resistant gastroenteropancreatic neuroendocrine tumors: a definition and guideline to medical and surgical managementBaylor University Medical Center Proceedings 2024; 37(1): 104 doi: 10.1080/08998280.2023.2284039
15
Efstathios Theodoros Pavlidis, Theodoros Efstathios Pavlidis. Molecular factors, diagnosis and management of gastrointestinal tract neuroendocrine tumors: An updateWorld Journal of Clinical Cases 2022; 10(27): 9573-9587 doi: 10.12998/wjcc.v10.i27.9573
16
Niko Hiltunen, Jukka Rintala, Juha P. Väyrynen, Jan Böhm, Tuomo J. Karttunen, Heikki Huhta, Olli Helminen. Monocarboxylate Transporters 1 and 4 and Prognosis in Small Bowel Neuroendocrine TumorsCancers 2022; 14(10): 2552 doi: 10.3390/cancers14102552
17
Giuseppe Iabichino, Milena Di Leo, Monica Arena, Giovanni Giuseppe Rubis Passoni, Elisabetta Morandi, Francesca Turpini, Paolo Viaggi, Carmelo Luigiano, Luca De Luca. Diagnosis, treatment, and current concepts in the endoscopic management of gastroenteropancreatic neuroendocrine neoplasmsWorld Journal of Gastroenterology 2022; 28(34): 4943-4958 doi: 10.3748/wjg.v28.i34.4943
18
Heying Duan, Andrei Iagaru. Neuroendocrine Tumor DiagnosisPET Clinics 2023; 18(2): 259 doi: 10.1016/j.cpet.2022.11.008
19
Daniel Hubbs, Thomas Fahey. Endocrine Surgery ClerkshipContemporary Surgical Clerkships 2024; : 221 doi: 10.1007/978-3-031-62091-1_25
20
Niko Hiltunen, Juha P. Väyrynen, Jan Böhm, Olli Helminen. CD3+, CD8+, CD4+ and FOXP3+ T Cells in the Immune Microenvironment of Small Bowel Neuroendocrine TumorsDiseases 2021; 9(2): 42 doi: 10.3390/diseases9020042
21
Federica De Muzio, Fabio Pellegrino, Roberta Fusco, Salvatore Tafuto, Mariano Scaglione, Alessandro Ottaiano, Antonella Petrillo, Francesco Izzo, Vincenza Granata. Prognostic Assessment of Gastropancreatic Neuroendocrine Neoplasm: Prospects and limits of RadiomicsDiagnostics 2023; 13(18): 2877 doi: 10.3390/diagnostics13182877
22
Catarina Almeida, Lorenzo Gervaso, Gianmaria Frigè, Francesca Spada, Lavinia Benini, Chiara Alessandra Cella, Luca Mazzarella, Nicola Fazio. The Role of Liquid Biopsy in Gastroenteropancreatic Neuroendocrine NeoplasmsCancers 2024; 16(19): 3349 doi: 10.3390/cancers16193349
23
Efstathios T Pavlidis, Ioannis N Galanis, Theodoros E Pavlidis. Critical considerations for the management of gastrointestinal mixed neuroendocrine non-neuroendocrine neoplasms and pure neuroendocrine carcinomasWorld Journal of Gastrointestinal Oncology 2024; 16(12): 4559-4564 doi: 10.4251/wjgo.v16.i12.4559
24
Vijay W. Dhakre, Sneha Tukaram Galande, Varsha Gunvant Patil, Nikita C. Shah, Chetan Rathod, Kaiumarz S. Sethna, Anjali D. Amrapurkar. Mixed Neuroendocrine and Non-Neuroendocrine Neoplasm of Pancreas: What Do We Know, What Have We Learnt?Gastrointestinal Tumors 2023; 10(1): 14 doi: 10.1159/000528759
25
Vincent Hautefeuille, Thomas Walter, Christine Do Cao, Romain Coriat, Sophie Dominguez, Laurent Mineur, Guillaume Cadiot, Eric Terrebonne, Iradj Sobhani, Delphine Gueguen, Aude Houchard, Charbel Mouawad, Amélie Anota, Pascal Hammel. OPERA: perception of information in patients with gastroenteropancreatic neuroendocrine tumors on lanreotide autogelEuropean Journal of Endocrinology 2023; 189(2): 281 doi: 10.1093/ejendo/lvad094